October 11, 2023
A New York judge on Wednesday appointed two institutional investors to lead a proposed shareholder action alleging biopharma company Syneos Health lied about its booming business during the COVID-19 pandemic, saying that the pair's $51 million alleged loss gives them the biggest financial interest in the case.
July 28, 2023
A Syneos Health Inc. shareholder alleges the company's leadership lied about its booming business during the COVID-19 pandemic when, in reality, a series of poor decisions caused the business to flounder, according to a proposed securities class action filed in New York federal court.